glp-1 als Why are agonists being used to treat patients with nonalcoholic fatty liver disease? The GLP-1 receptor agonist, liraglutide,

Start Your weight Loss Journey With Expert Guidance Lipotropics or GLP-1s

Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice

Whilst research suggests potential benefits, the evidence base has important limitations that must be acknowledged

Cagrilintide is a synthetic long-acting peptide studied in non-clinical research models related to amylin receptor signaling, calcitonin receptor activity, metabolic regulation, appetite-associated pathways, and energy homeostasis

This breadth of action distinguishes it from growth factors with a narrow receptor focus and helps explain experimentally observed tissue protection across different organ systems

Used in laboratory workflows as the standard diluent for reconstituting lyophilized research peptides